By Nicole Blazek Patients that were administered the three-dose quadrivalent human papillomavirus vaccine (Gardasil, Merck) with longer intervals between each dose had similar immune responses to those administered the vaccine on a standard dosing schedule, new data indicate. “Clinicians can be reassured that if delays occur in administering the second and third doses of this […]